For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250801:nRSA6682Ta&default-theme=true
RNS Number : 6682T Reckitt Benckiser Group PLC 01 August 2025
RECKITT BENCKISER GROUP PLC
DIRECTOR/PDMR SHAREHOLDINGS
Reckitt Benckiser Group plc (the "Company") announces the following changes in
the interests of Directors and Persons Discharging Managerial Responsibility
("PDMR") in ordinary shares of 10 pence each in the share capital of the
Company ("Shares").
Vesting of Replacement Award
As previously announced on 27 October 2023, Shannon Eisenhardt, Chief
Financial Officer, was awarded 5,248 performance Shares on 26 October 2023 in
relation to the long-term incentive award over NIKE, Inc. shares granted to
Shannon in August 2022, and vesting based on the measures and targets for the
Reckitt 2022 LTIP award (as disclosed in the Company's 2021 and 2024 Annual
Report). The shares will vest at 68% with a total of 3,568 shares. As part of
the award, Shannon was also entitled to an accrual of 248 shares by way of a
dividend equivalent on the award. 1,798 shares were sold on 1 August 2025 at a
price of £56.54 per share to release sufficient funds to settle the
resultant tax and social security liabilities arising from the vesting.
The following notifications are made in accordance with DTR 3.1.2-A,
incorporating article 19(1) of the Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Shannon Eisenhardt
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/ Initial notification
Amendment
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Reckitt Benckiser Group plc
b) LEI 5493003JFSMOJG48V108
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10p each in Reckitt Benckiser Group plc
Identification code
GB00B24CGK77
b) Nature of the transaction Vesting of replacement share awards in relation to former employment with
NIKE, Inc and accrual of dividend equivalent shares.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 3,816
d) Aggregated information
Aggregated volume N/A
Price
e) Date of the transaction 2025-08-01
f) Place of the transaction Outside a Trading Venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10p each in Reckitt Benckiser Group plc
Identification code GB00B24CGK77 - ID code for ordinary shares
b) Nature of the transaction Sale of shares to settle tax liabilities arising from vesting of replacement
share award and dividend equivalent shares.
c) Price(s) and volume(s)
Price(s) Volume(s)
£56.54 1,798
d) Aggregated information Aggregate Price Aggregate Volume Aggregate Total
£56.54 1,798 £101,658.92
- Aggregated volume
- Price
e) Date of the transaction 2025-08-01
f) Place of the transaction London Stock Exchange, Main Market - XLON
d)
Aggregated information
Aggregated volume
Price
N/A
e)
Date of the transaction
2025-08-01
f)
Place of the transaction
Outside a Trading Venue
4
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each in Reckitt Benckiser Group plc
GB00B24CGK77 - ID code for ordinary shares
b)
Nature of the transaction
Sale of shares to settle tax liabilities arising from vesting of replacement
share award and dividend equivalent shares.
c)
Price(s) and volume(s)
Price(s) Volume(s)
£56.54 1,798
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£56.54 1,798 £101,658.92
e)
Date of the transaction
2025-08-01
f)
Place of the transaction
London Stock Exchange, Main Market - XLON
CONTACT DETAILS:
Contacts
Nick Ashworth
+44 (0) 7408 812350
Investor Relations
Catheryn O'Rourke
+44 (0) 1753 217 800
General Counsel & Company Secretary
About Reckitt:
We make the products people trust to care for the ones they love. We are home
to some of the world's best-loved consumer health and hygiene brands,
including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen,
Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By
creating innovative, science-backed solutions, we support people every day to
live healthier lives.
Reckitt exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. This commitment goes beyond the products we make. Through our
actions, we expand access to healthcare, education and economic opportunities.
We support the planet by reducing waste, conserving resources and driving
sustainable innovation.
We believe good health starts at home. With every action we take, we strive to
make our consumers' lives easier, cleaner and healthier, to strengthen
communities and to create a more sustainable future.
* Reckitt is the trading name of the Reckitt Benckiser group of companies
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBBGDICDGDGUB